• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • Industry News
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
  • Newsletters
    • CBE Week
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
  • Contact
  • Last Chance to Submit for the 2019 CBE Ancillary Business List CLICK HERE
You are here: Home / Policy & Legal / Oregon / New Medical Rules in Oregon…What a Mess!
Oregon Recreational Marijuana Sales Lines Midnight Oregon Sales Medical Rules in Oregon Selling to Cannabis Industry

New Medical Rules in Oregon…What a Mess!

October 24, 2016 by Matt Walstatter 1 Comment

By Matt Walstatter

My last article in CBE focused on the launch of Oregon’s Liquor Control Commission’s (OLCC) regulated recreational cannabis system, which has proceeded in fits and starts. The Oregon Health Authority (OHA) simultaneously implemented new rules for the medical system, which are causing some major ripples of their own.

The OHA-regulated medical system remains important since most sales in the state, including the majority of recreational sales, continue to take place in OHA-licensed medical stores. Recall that medical stores are temporarily authorized to sell limited products to recreational customers. This authorization sunsets at the end of this year, but until then, medical stores are doing most of the heavy lifting in Oregon.

The changes implemented on October 1 represent the most substantial modifications to the medical program in some time. What follows is a list of the most significant and impactful new rules.

Packaging and Labeling

Beginning October 1, all cannabis products sold in OHA-licensed dispensaries must be contained in a pre-approved package with a pre-approved label. In a rare instance of communication and coordination, the OLCC is handling all packaging and labeling approvals—even for OHA-licensed businesses.

The main criteria for approval of packaging is that it be childproof. Packages that are not childproof, but are otherwise compliant may be placed in a childproof exit bag. Single use items must be childproof when they leave the store. Multiple use items must have resealable, continuously childproof packaging. Packages that contain misleading information or are attractive to minors will not be approved.

The labeling requirements are more complex and detailed. Each type of product (flower, extract etc.) has different rules regarding what must be on the label. These rules specify information like product name, batch number, lab testing information and much more that must appear on the label. They also require specific warnings and the state’s universal symbol. The rules even set minimum font sizes and mandate that certain information be found in certain, specific areas of the packaging.

Keep in mind that not only must the packages and labels comply with all rules, they must also be specifically approved by regulators for each specific business and product. That being said, the state has provided a bit of wiggle room.

For packaging, once a package is approved by the OLCC, it goes on the approved list and other businesses may use it without receiving additional approval. This allows manufacturers of packaging to obtain pre-approval for their products and sell them as such, a significant value-add for their customers.

On the labeling side, a label that contains all required information and would be approvable by the OLCC may avoid the approval process if it is generic. A generic label is one that contains only type, with no images of any kind other than the universal symbol.

Licensing

Until early this year, medical cannabis stores bought all cannabis products from medical cardholders; no licenses for processors existed. Beginning last March, the state began requiring that all extracts be purchased from a licensed processor. Because of the long approval process, processors who have completed their application are placed on a list, and are authorized to process and sell products until they are either approved or denied for a license.

Beginning October 1, this requirement was extended to all other categories of processed products—concentrates, edibles, tinctures, capsules, topicals etc. A dispensary can only purchase these products from processors who have secured a license or who have at least completed the application.

This rule will change again on January 1. Beginning then, processors must actually be licensed in order to sell products to dispensaries. At that point, a completed application will no longer be sufficient.

Concentration Limits

Prior to October 1, 2016, medical edibles had no upper limit on potency. An edible could contain 10 mg, 100 mg or 1,000 mg of THC. The new rules cap the concentration of medical edibles at a maximum of 100 mg THC.

This is a concern for many medical patients who rely on high dose edibles to manage symptoms and treat diseases. They will now be forced to buy several products to obtain the medicine that they need. This is something that we’ll be watching closely.

Recreational edibles sold at OLCC-licensed rec stores can contain up to 50 mg THC, but these edibles cannot be sold to rec customers at OHA-licensed medical shops. Rec customers purchasing edibles at medical stores remain subject to the early start rules, which allow them one edible per day with a maximum of 15 mg THC.

Lab Testing

The new lab testing rules are by far the most problematic of the new medical rules for Oregon’s cannabis community. In fact, the new testing requirements are so rigorous and costly that they currently pose an existential threat to the entire industry.

New licensing requirements have reduced the number of labs from somewhere between 30-40 to less than ten. Of these ten, only four are licensed to screen for pesticides. This lack of lab capacity has pushed up prices and created a huge bottleneck in the system.

The lack of lab capacity combined with the increased regulatory burden has driven the price of a lab test from about $100 per test to $300-$400 per test.

The new rules also require labs to pull substantially more samples and to perform many more tests, sending costs through the roof. Here’s an example of just how burdensome the system has become.

Prior to October 1, a 300 gram batch of shatter would need one test at a cost of approximately $100. Now, that same batch would require eight tests, which could cost as much as $3,500 ($3,200 for testing, plus the value of the eight samples). All for a batch of shatter worth about $4,500.

Oregon businesses and organizations like the Oregon Cannabis Association are lobbying hard for immediate changes. Next time I’ll cover the lab situation in more detail, including more information about the rules themselves and the industry’s response to this crisis.

 

Contextual Link – Nexus November

Contextual Link – Cova November

Filed Under: Oregon, Policy & Legal Tagged With: medical marijuana, Oregon, Oregon Cannabis Rules, Oregon Liquor Control Commission (OLCC), recreational

About The Author:

Matt Walstatter

Matt Walstatter and his wife, Meghan, are the owners of Pure Green, a patient owned and operated dispensary in Portland, Oregon. They have jointly owned and operated cultivation centers since 2001. Their dispensary opened in 2013. Matt can be reached at (971) 242-8561 or [email protected]

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Resource Protection Specialist I/II (Permanent and Limited Term) - County of San Luis Obispo - San Luis Obispo, CA
  • LC/MS Lab Manager Biomarker Discovery - VRS Recruitment - , ME
  • Senior Bioinformatics Scientist - Medicinal Genomics Corp. - Beverly,

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Industry Blogs



Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2018 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·